High-resolution 18F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritis

Published on Jan 30, 2010in European Journal of Nuclear Medicine and Molecular Imaging7.081
· DOI :10.1007/S00259-009-1364-X
Abhijit J. Chaudhari18
Estimated H-index: 18
(UC Davis: University of California, Davis),
Spencer L. Bowen11
Estimated H-index: 11
(UC Davis: University of California, Davis)
+ 9 AuthorsRamsey D. Badawi29
Estimated H-index: 29
(UC Davis: University of California, Davis)
Sources
Abstract
Eur J Nucl Med Mol Imaging (2010) 37:1047 DOI 10.1007/s00259-009-1364-x IMAGE OF THE MONTH High-resolution 18 F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritis Abhijit J. Chaudhari & Spencer L. Bowen & George W. Burkett & Nathan J. Packard & Felipe Godinez & Anand A. Joshi & Stanley M. Naguwa & David K. Shelton & John C. Hunter & John M. Boone & Michael H. Buonocore & Ramsey D. Badawi Received: 20 November 2009 / Accepted: 10 December 2009 / Published online: 30 January 2010 # The Author(s) 2010. This article is published with open access at Springerlink.com Molecular imaging can potentially provide means for mon- itoring response to therapy in rheumatoid arthritis (RA) early in the course of disease [1].Quantitative measurements of RA disease activity made in the wrist by whole-body PET scanners, however, have inadequate accuracy because of limited spatial resolution [2]. A high-resolution PET/CT scanner for imaging extremities has been built at our insti- tution [3]. In conjunction with a clinical MRI scanner, high- resolution PET/MR images can be obtained for the wrist. The CT image is used for PET/MR image coregistration. A 57-year-old female with established RA was stable until a recent clinical flare-up in the right wrist. Clinical exami- nation revealed synovitis, swelling, and diminished range of motion. The patient also had a history of osteoarthritis (OA). An extremity 18 F-FDG PET/CT scan immediately following MRI at baseline was performed on this patient. Tumor necrosis factor alpha (TNF-α) inhibitor (etanercept) therapy was then initiated as a part of the patient’s standard of care. The patient was re-scanned 5 weeks after starting treatment. The figure shows high-resolution 18 F-FDG PET images (pseudocolor) overlaid on pre-contrast MRI images (gray This work was funded by the NIH grants UL1-RR024146, R01CA129561, R01EB002138 and the UC Davis Imaging Research Center. A. J. Chaudhari (*) : S. L. Bowen : G. W. Burkett : N. J. Packard : F. Godinez : D. K. Shelton : J. C. Hunter : J. M. Boone : M. H. Buonocore : R. D. Badawi Department of Radiology, UC Davis Medical Center, Sacramento, CA, USA e-mail: ajchaudhari@ucdavis.edu A. A. Joshi Department of Neurology, UCLA School of Medicine, Los Angeles, CA, USA S. M. Naguwa Department of Internal Medicine, UC Davis Medical Center, Sacramento, CA, USA scale) at baseline (left column) and 5 weeks (right column). Significant reduction in PET signal (suggesting reduced inflammation) in the synovium and at sites of erosions (white arrows) is visible. The green arrow shows inflammation due to OA. Physician examination at 3 months confirmed that this patient responded positively to etanercept. This case illustrates the potential of high-resolution PET with MRI for quantitative visualization of early response to therapy in RA. Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which per- mits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. References 1. Brenner W. 18F-FDG PET in rheumatoid arthritis: there still is a long way to go. J Nucl Med. 2004;45(6):927–9. 2. Beckers C, Ribbens C, Andre B, Marcelis S, Kaye O, Mathy L, et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med. 2004;45(6):956–64. 3. Bowen SL, Wu Y, Chaudhari AJ, Fu L, Packard NJ, Burkett GW, et al. Initial characterization of a dedicated breast PET/CT scanner during human imaging. J Nucl Med. 2009;50(9):1401–8.
📖 Papers frequently viewed together
199 Citations
192 Citations
109 Citations
References3
Newest
#1Spencer L. Bowen (UC Davis: University of California, Davis)H-Index: 11
#2Yibao Wu (UC Davis: University of California, Davis)H-Index: 17
Last. Ramsey D. BadawiH-Index: 29
view all 16 authors...
Whole-body (WB) 18F-FDG PET has clinical utility in breast cancer staging, restaging, and therapy response assessment. A study by Rousseau et al. (1) found that WB PET could identify tumors with pathologic response after a single course of neoadjuvant chemotherapy (sensitivity, 61%; specificity, 96%), whereas mammography had limited accuracy (sensitivity, 31%; specificity, 56%), even after 6 courses of treatment. WB PET has been shown to have a high accuracy for detecting distant metastasis. Mah...
101 CitationsSource
#1Catherine BeckersH-Index: 6
#2Clio RibbensH-Index: 18
Last. Michel Malaise (University of Liège)H-Index: 51
view all 10 authors...
The aim of this study was to assess synovitis by 1 8 F-FDG PET in an individual joint analysis and in a global analysis of rheumatoid arthritis (RA) disease activity and to compare 1 8 F-FDG PET parameters with clinical, biologic, and sonographic (US) rheumatoid parameters. Methods: Three hundred fifty-six joints were assessed in 21 patients with active RA: the knees in all subjects and either wrists as well as metacarpophalangeal and proximal interphalangeal joints in 13 patients, or ankles and...
199 Citations
#1Winfried Brenner (University of Washington Medical Center)H-Index: 6
Rheumatoid arthritis (RA) is a chronic progressive disease with a high worldwide prevalence—860/100,000— and the highest incidence of all autoimmune diseases—21.8/100,000 in persons older than 16 y ([1][1]). RA is a multisystem disorder characterized by destructive synovitis and inflammation,
19 Citations
Cited By37
Newest
#1Abhijit J. Chaudhari (UC Davis: University of California, Davis)H-Index: 18
#2William Raynor (Drexel University)H-Index: 8
Last. Abass Alavi (UPenn: University of Pennsylvania)H-Index: 130
view all 6 authors...
Imaging of musculoskeletal disorders, including arthritis, infection, osteoporosis, sarcopenia, and malignancies, is often limited when using conventional modalities such as radiography, computed tomography (CT), and MR imaging. As a result of recent advances in Positron Emission Tomography (PET) instrumentation, total-body PET/CT offers a longer axial field-of-view, higher geometric sensitivity, and higher spatial resolution compared with standard PET systems. This article discusses the potenti...
1 CitationsSource
#1Kathleen M. Capaccione (Columbia University)H-Index: 3
#2Mikhail Doubrovin (Columbia University)
Last. Andrei Molotkov (Columbia University)H-Index: 21
view all 5 authors...
The human immune system is a complex system which protects against invaders and maintains tissue homeostasis. It is broadly divided into the innate and adaptive branches. Granzyme B is serine protease that plays an important role in both and can serve as a biomarker for cellular activation. Because of this, a granzyme B PET agent (GZP) has recently been developed and has been shown to be able to monitor response to immunotherapy. Here, we evaluated the utility of granzyme B PET imaging to assess...
1 CitationsSource
Purpose While the aetiology of rheumatoid arthritis (RA) remains unclear, many of the inflammatory components are well characterised. For diagnosis and therapy evaluation, in vivo insight into these processes would be valuable. Various imaging probes have shown value including dynamic contrast-enhanced (DCE) MRI and PET/CT using 18F-fluorodeoxyglucose (18F-FDG) or tracers targeting the translocator protein (TSPO). To evaluate 18F-GE-180, a novel TSPO PET tracer, for detecting and quantifying dis...
8 CitationsSource
#1Philipp Guenthoer (University of Tübingen)H-Index: 1
#2Kerstin Fuchs (University of Tübingen)H-Index: 11
Last. Manfred Kneilling (University of Tübingen)H-Index: 23
view all 8 authors...
Background Mitogen-activated protein kinase (MAPK) signaling plays an important role in inflammatory diseases such as rheumatoid arthritis (RA).The aim of our study was to elucidate the therapeutic potential of the highly selective p38 MAPK inhibitor Skepinone-L and the dual inhibitor LN 950 (p38 MAPK and JNK 3) in the K/BxN serum transfer model of RA. Additionally, we aimed to monitor MAPK treatment non-invasively in vivo using the hypoxia tracer [18F]fluoromisonidazole ([18F]FMISO) and positro...
5 CitationsSource
#1Martina Sollini (Humanitas University)H-Index: 22
#2Raffaella Nice Berchiolli (UniPi: University of Pisa)H-Index: 14
Last. Paola Anna Erba (UniPi: University of Pisa)H-Index: 31
view all 7 authors...
Hybrid positron emission tomography/magnetic resonance imaging (PET/MR) systems are now more and more available for clinical use. PET/MR combines the unique features of MR including excellent soft tissue contrast, diffusion-weighted imaging, dynamic contrast-enhanced imaging, fMRI and other specialized sequences as well as MR spectroscopy with the quantitative physiologic information that is provided by PET. Most of the evidence of the potential clinical utility of PET/MRI is available for neuro...
18 CitationsSource
#1Felipe Godinez ('KCL': King's College London)H-Index: 4
#2Kuang Gong (UC Davis: University of California, Davis)H-Index: 13
Last. Ramsey D. Badawi (UC Davis: University of California, Davis)H-Index: 29
view all 6 authors...
A positron emission tomography (PET) scanner with submillimeter spatial resolution, capable of in vivo imaging of murine extremities was built based on two dual ended readout, hybrid depth of interaction (DOI) PET detectors. Each was composed of a 36 {\times } \,\, 36array of 0.43 mm {\times } \,\, 0.43mm {\times } \,\, 8mm unpolished lutetium oxyorthosilicate crystals separated by a 50~\boldsymbol \mu \text{m}white diffuse reflector. The array was coupled to a position-sensing photo...
5 CitationsSource
#1Nehal Narayan (University of Oxford)H-Index: 5
#2David R. Owen (Imperial College London)H-Index: 71
Last. Peter C. Taylor (University of Oxford)H-Index: 69
view all 3 authors...
: Imaging techniques, such as US, are well recognized as important tools to aid early diagnosis and assess response to treatment in RA. PET offers a means of imaging the inflammatory processes of RA at a cellular level and thus may be a highly sensitive method of assessing synovitis. In this review we discuss the advantages of PET as an imaging modality for RA and summarize the existing clinical studies of PET in RA. We also highlight potentially important preclinical studies of PET in arthritis...
14 CitationsSource
#1Daniel L Franze (USP: University of São Paulo)
#2A. F. Andre Martins (USP: University of São Paulo)
Last. Eder Rezende Moraes (USP: University of São Paulo)H-Index: 7
view all 3 authors...
Considering the human cross section is not exactly a circle and the fact that sensitivity and spatial resolution of PET images formed in coincidence may show better values with reduction of the distance between the coincident detectors three different detection geometries of a PET system have been simulated: one circular and two elliptical. The performance evaluation was done by system parameters: sensitivity, resolution and the Noise Equivalent Count Rate curve. The elliptical systems presented...
Source
#1Kazuo KubotaH-Index: 55
#2Hiroyuki YamashitaH-Index: 33
Last. Akio MimoriH-Index: 27
view all 3 authors...
FDG is a tracer for visualizing glucose metabolism. PET/CT using FDG is widely used for the diagnosis of cancer, because glycolysis is elevated in cancer cells. Similarly, active inflammatory tissue also exhibits elevated glucose metabolism because of glycolysis in activated macrophages and proliferating fibroblasts. Elevated FDG uptake by active inflammatory tissues, such as those affected by arthritis, vasculitis, lymphadenitis, and chondritis, has enabled the diagnosis of inflammatory disease...
38 CitationsSource
Source